Jamie BernardView profile
Associate Professor
Dr. Jamie Bernard is an Associate Professor and Director of the Ph.D. Program in Pharmacology & Toxicology at Michigan State University (MSU), affiliated with the College of Human Medicine. Her research focuses on mechanisms linking environmental exposures, obesity, and carcinogenesis, particularly the role of adipose tissue-derived factors like FGF2 in promoting cancer. She leads the Bernard Lab, which explores chemopreventive agents and inflammatory pathways in obesity-associated malignancies. Dr. Bernard holds a PhD in Pharmacology and Toxicology. Her work spans drug discovery, immune modulation, and translational biomarker development. She teaches courses including PHM 828 Concepts in Carcinogenesis and PHM 802 Pharmacology . Her research highlights include identifying FGF2's role in adiposity-driven breast cancer, UV radiation's effects on immune signaling, and developing high-throughput assays for chemoprevention screening. She collaborates with MSU's Integrated Pharmacological Sciences and Environmental Toxicology programs. Dr. Bernard advises three graduate students and has published extensively in Nature Medicine , Oncogene , and Journal of Investigative Dermatology . Her lab's work aims to translate mechanistic findings into clinical applications for cancer prevention and treatment.








